These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. Neame PB; Soamboonsrup P; Leber B; Carter RF; Sunisloe L; Patterson W; Orzel A; Bates S; McBride JA Am J Hematol; 1997 Nov; 56(3):131-42. PubMed ID: 9371524 [TBL] [Abstract][Full Text] [Related]
17. Relapsed Acute Promyelocytic Leukemia Lacks "Classic" Leukemic Promyelocyte Morphology and Can Create Diagnostic Challenges. Dayton VJ; McKenna RW; Yohe SL; Dolan MM; Courville E; Alvarez H; Linden MA Am J Clin Pathol; 2017 Jan; 147(1):69-76. PubMed ID: 28108472 [TBL] [Abstract][Full Text] [Related]
18. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia]. Korístek Z; Zák P Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573 [TBL] [Abstract][Full Text] [Related]
19. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767 [TBL] [Abstract][Full Text] [Related]
20. Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience. Wang H; Hao L; Wang X; Li J; Wu Q; Bian S Int J Hematol; 2010 Jun; 91(5):820-5. PubMed ID: 20461563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]